These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21455275)

  • 41. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes.
    Farías M; San Martín R; Puebla C; Pearson JD; Casado JF; Pastor-Anglada M; Casanello P; Sobrevia L
    J Cell Physiol; 2006 Aug; 208(2):451-60. PubMed ID: 16688763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.
    Sundaram M; Yao SY; Ingram JC; Berry ZA; Abidi F; Cass CE; Baldwin SA; Young JD
    J Biol Chem; 2001 Nov; 276(48):45270-5. PubMed ID: 11584005
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the mitochondrial targeting signal of the human equilibrative nucleoside transporter 1 (hENT1): implications for interspecies differences in mitochondrial toxicity of fialuridine.
    Lee EW; Lai Y; Zhang H; Unadkat JD
    J Biol Chem; 2006 Jun; 281(24):16700-6. PubMed ID: 16595656
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Uridine recognition motifs of human equilibrative nucleoside transporters 1 and 2 produced in Saccharomyces cerevisiae.
    Vickers MF; Zhang J; Visser F; Tackaberry T; Robins MJ; Nielsen LP; Nowak I; Baldwin SA; Young JD; Cass CE
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):361-73. PubMed ID: 15043160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential expression of human nucleoside transporters in normal and tumor tissue.
    Pennycooke M; Chaudary N; Shuralyova I; Zhang Y; Coe IR
    Biochem Biophys Res Commun; 2001 Jan; 280(3):951-9. PubMed ID: 11162617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms.
    Hyde RJ; Cass CE; Young JD; Baldwin SA
    Mol Membr Biol; 2001; 18(1):53-63. PubMed ID: 11396612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification and mutational analysis of amino acid residues involved in dipyridamole interactions with human and Caenorhabditis elegans equilibrative nucleoside transporters.
    Visser F; Baldwin SA; Isaac RE; Young JD; Cass CE
    J Biol Chem; 2005 Mar; 280(12):11025-34. PubMed ID: 15649894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assembly Characterization of Human Equilibrium Nucleoside Transporter 1 (hENT1) by Inhibitor Probe-Based dSTORM Imaging.
    Sui B; Chen J; Ge D; Liang F; Wang H
    Anal Chem; 2023 Jun; 95(24):9207-9218. PubMed ID: 37276019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Role of Flexible Loops in Folding, Trafficking and Activity of Equilibrative Nucleoside Transporters.
    Aseervatham J; Tran L; Machaca K; Boudker O
    PLoS One; 2015; 10(9):e0136779. PubMed ID: 26406980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetic profiling of novel spirobenzo-oxazinepiperidinone derivatives as equilibrative nucleoside transporter 1 inhibitors.
    Vlachodimou A; Bouma J; De Cleyn M; Berthelot D; Pype S; Bosmans JP; van Vlijmen H; Wroblowski B; Heitman LH; IJzerman AP
    Purinergic Signal; 2024 Apr; 20(2):193-205. PubMed ID: 37423967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting human equilibrative nucleoside analog transporter (hENT1) expression through modified low glycemic index diet in pancreatic cancer.
    Pazienza V; Del Nobile Matteo A
    Biomed Pharmacother; 2014 Jun; 68(5):663-4. PubMed ID: 24874245
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring novel dilazep derivatives as hENT1 inhibitors and potentially covalent molecular tools.
    Dilweg MA; Gorostiola González M; de Ruiter MD; Meijboom NJ; van Veldhoven JPD; Liu R; Jespers W; van Westen GJP; Heitman LH; IJzerman AP; van der Es D
    Purinergic Signal; 2024 Jun; ():. PubMed ID: 38879664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insight into the nucleoside transport and inhibition of human ENT1.
    Wu Z; Han Z; Zhou W; Sun X; Chen L; Yang S; Hu J; Li C
    Curr Res Struct Biol; 2022; 4():192-205. PubMed ID: 35677775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of the Augustine blood group system.
    Zhong J; Mo C; Zhang Y; Li L
    Int J Hematol; 2024 Jul; 120(1):44-49. PubMed ID: 38767828
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthetic single domain antibodies for the conformational trapping of membrane proteins.
    Zimmermann I; Egloff P; Hutter CA; Arnold FM; Stohler P; Bocquet N; Hug MN; Huber S; Siegrist M; Hetemann L; Gera J; Gmür S; Spies P; Gygax D; Geertsma ER; Dawson RJ; Seeger MA
    Elife; 2018 May; 7():. PubMed ID: 29792401
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMPROvER: the Integral Membrane Protein Stability Selector.
    Harborne SPD; Strauss J; Boakes JC; Wright DL; Henderson JG; Boivineau J; Jaakola VP; Goldman A
    Sci Rep; 2020 Sep; 10(1):15165. PubMed ID: 32938971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenosine A1 receptor activation modulates human equilibrative nucleoside transporter 1 (hENT1) activity via PKC-mediated phosphorylation of serine-281.
    Hughes SJ; Cravetchi X; Vilas G; Hammond JR
    Cell Signal; 2015 May; 27(5):1008-18. PubMed ID: 25725289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel variants provide differential stabilisation of human equilibrative nucleoside transporter 1 states.
    Boakes JC; Harborne SPD; Ngo JTS; Pliotas C; Goldman A
    Front Mol Biosci; 2022; 9():970391. PubMed ID: 36425655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Strategies for Successful Over-Expression of Human Membrane Transport Systems Using Bacterial Hosts: Future Perspectives.
    Galluccio M; Console L; Pochini L; Scalise M; Giangregorio N; Indiveri C
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409183
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.